Log In
BCIQ
Print this Print this
 

Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)

BCIQ
Print ChartPrint this
0 2 0 0 0 0 1 0 1 1 0 1 1 2 0 0
Phases of DevelopmentPhase IPhase IIPhase IIIMarketed
Autoimmune

1

2

0

0

Cancer

1

1

0

1

Hematology

0

0

1

0

Inflammation

0

2

0

0




 Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$5,849.9M

$102.5M

$12.6M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today